BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38730456)

  • 21. Diverse fusion patterns and heterogeneous clinicopathologic features of renal cell carcinoma with t(6;11) translocation.
    Inamura K; Fujiwara M; Togashi Y; Nomura K; Mukai H; Fujii Y; Yamamoto S; Yonese J; Fukui I; Ishikawa Y
    Am J Surg Pathol; 2012 Jan; 36(1):35-42. PubMed ID: 22173116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re-evaluation of histological type by immunohistochemical and genetic study of transcription factors (TFE3 and TFEB) of VHL gene mutation-negative clear cell renal cell carcinoma and other special types of renal tumor.
    Kuroda N; Kawada C; Tamura K; Hiroi M; Hes O; Michal M; Wada Y; Inoue K; Ohara M; Mizuno K; Shuin T; Lee GH
    Med Mol Morphol; 2011 Mar; 44(1):46-51. PubMed ID: 21424937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms.
    Caliò A; Marletta S; Brunelli M; Pedron S; Portillo SC; Segala D; Bariani E; Gobbo S; Netto G; Martignoni G
    Virchows Arch; 2022 Dec; 481(6):877-891. PubMed ID: 35980471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sarcomatoid renal cell tumor harboring a novel BYSL::TFEB fusion with concurrent TFEB amplification.
    Lin R; Flerova E; Wamsley CE; McCue PA; Lallas CD; Jiang W; Huang J; Wang ZX; Li L
    Genes Chromosomes Cancer; 2023 Jun; 62(6):353-360. PubMed ID: 36704911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Xp11 Translocation Renal Cell Carcinomas (RCCs) With RBM10-TFE3 Gene Fusion Demonstrating Melanotic Features and Overlapping Morphology With t(6;11) RCC: Interest and Diagnostic Pitfall in Detecting a Paracentric Inversion of TFE3.
    Xia QY; Wang XT; Zhan XM; Tan X; Chen H; Liu Y; Shi SS; Wang X; Wei X; Ye SB; Li R; Ma HH; Lu ZF; Zhou XJ; Rao Q
    Am J Surg Pathol; 2017 May; 41(5):663-676. PubMed ID: 28288037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive study of three novel cases of TFEB-amplified renal cell carcinoma and review of the literature: Evidence for a specific entity with poor outcome.
    Mendel L; Ambrosetti D; Bodokh Y; Ngo-Mai M; Durand M; Simbsler-Michel C; Delhorbe M; Amiel J; Pedeutour F
    Genes Chromosomes Cancer; 2018 Mar; 57(3):99-113. PubMed ID: 29127730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal cell carcinomas with t(6;11)(p21;q12) presenting with tubulocystic renal cell carcinoma-like features.
    Rao Q; Zhang XM; Tu P; Xia QY; Shen Q; Zhou XJ; Shi QL
    Int J Clin Exp Pathol; 2013; 6(7):1452-7. PubMed ID: 23826432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma.
    Wang XM; Zhang Y; Mannan R; Skala SL; Rangaswamy R; Chinnaiyan A; Su F; Cao X; Zelenka-Wang S; McMurry L; Xiao H; Spratt DE; Sangoi AR; Shao L; Betz BL; Brown N; Tickoo SK; McKenney JK; Argani P; Gupta S; Reuter VE; Chinnaiyan AM; Dhanasekaran SM; Mehra R
    Mod Pathol; 2021 Aug; 34(8):1596-1607. PubMed ID: 33854184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular-genetic analysis is essential for accurate classification of renal carcinoma resembling Xp11.2 translocation carcinoma.
    Hayes M; Peckova K; Martinek P; Hora M; Kalusova K; Straka L; Daum O; Kokoskova B; Rotterova P; Pivovarčikova K; Branzovsky J; Dubova M; Vesela P; Michal M; Hes O
    Virchows Arch; 2015 Mar; 466(3):313-22. PubMed ID: 25544614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lessons from 801 clinical TFE3/TFEB fluorescence in situ hybridization assays performed on renal cell carcinoma suspicious for MiTF family aberrations.
    Wang XM; Shao L; Xiao H; Myers JL; Pantanowitz L; Skala SL; Udager AM; Vaishampayan U; Mannan R; Dhanasekaran SM; Chinnaiyan AM; Betz BL; Brown N; Mehra R
    Am J Clin Pathol; 2023 Dec; 160(6):549-554. PubMed ID: 37499055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [TFEB-amplified renal cell carcinoma. A case report and review of the literature].
    Mayoral Guisado C; Gómez Durán Á; Agustín Benítez López D; Toro Zambrano W; Rubio Fernández A; Moreno Ontalba A; Díaz Delgado M
    Rev Esp Patol; 2018; 51(4):248-252. PubMed ID: 30269777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aggressive and nonaggressive translocation t(6;11) renal cell carcinoma: comparative study of 6 cases and review of the literature.
    Peckova K; Vanecek T; Martinek P; Spagnolo D; Kuroda N; Brunelli M; Vranic S; Djuricic S; Rotterova P; Daum O; Kokoskova B; Vesela P; Pivovarcikova K; Bauleth K; Dubova M; Kalusova K; Hora M; Michal M; Hes O
    Ann Diagn Pathol; 2014 Dec; 18(6):351-7. PubMed ID: 25438924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translocation renal cell carcinomas in adults: a single-institution experience.
    Zhong M; De Angelo P; Osborne L; Paniz-Mondolfi AE; Geller M; Yang Y; Linehan WM; Merino MJ; Cordon-Cardo C; Cai D
    Am J Surg Pathol; 2012 May; 36(5):654-62. PubMed ID: 22446944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review of TFEB-amplified renal cell carcinoma with focus on clinical and pathobiological aspects.
    Kuroda N; Sugawara E; Ohe C; Kojima F; Ohashi R; Mikami S; Nagashima Y; Peckova K; Michal M; Hes O
    Pol J Pathol; 2021; 72(3):197-199. PubMed ID: 35048631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TFEB Rearranged Renal Cell Carcinoma: Pathological and Molecular Characterization of 10 Cases, with Novel Clinical Implications: A Single Center 10-Year Experience.
    Wang AX; Tian T; Liu LB; Yang F; He HY; Zhou LQ
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Tale of 2 Morphologies: Diagnostic Pitfalls in
    Sharma AE; Parilla M; Wanjari P; Segal JP; Antic T
    Int J Surg Pathol; 2021 Feb; 29(1):21-29. PubMed ID: 32886007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma.
    Pei J; Cooper H; Flieder DB; Talarchek JN; Al-Saleem T; Uzzo RG; Dulaimi E; Patchefsky AS; Testa JR; Wei S
    Mod Pathol; 2019 May; 32(5):710-716. PubMed ID: 30622287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal Cell Carcinoma With Chromosome 6p Amplification Including the TFEB Gene: A Novel Mechanism of Tumor Pathogenesis?
    Williamson SR; Grignon DJ; Cheng L; Favazza L; Gondim DD; Carskadon S; Gupta NS; Chitale DA; Kalyana-Sundaram S; Palanisamy N
    Am J Surg Pathol; 2017 Mar; 41(3):287-298. PubMed ID: 28009604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clear cell renal cell carcinoma with focal psammomatous calcifications: a rare occurrence mimicking translocation carcinoma.
    Sangoi AR; Al-Obaidy KI; Cheng L; Kao CS; Chan E; Sadasivan S; Levin AM; Alvarado-Cabrero I; Kunju LP; Mehra R; Mannan R; Wang X; Dhillon J; Tretiakova M; Smith SC; Hes O; Williamson SR
    Histopathology; 2023 Apr; 82(5):684-690. PubMed ID: 36564980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of TFE3 translocation renal cell carcinoma with rare morphological features and literature review.
    Xia T; Long H; Liao D; Wang W; Xiao X
    Indian J Pathol Microbiol; 2023; 66(1):135-140. PubMed ID: 36656224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.